|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
2009-11-10
|
|
pubmed:abstractText |
Huachansu, a Chinese medicine that comes from dried toad venom from the skin glands of Bufo gargarizans or B. melanostictus, has been used in the treatment of various cancers in China. The authors conducted a pilot study, using a phase 1 trial design, of huachansu in patients with advanced cancer.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:BeiWenyingW,
pubmed-author:ChangDavid ZDZ,
pubmed-author:CohenLorenzoL,
pubmed-author:GeYongqianY,
pubmed-author:KurzrockRazelleR,
pubmed-author:LiaoZongxingZ,
pubmed-author:LiuLumingL,
pubmed-author:MengZhiqiangZ,
pubmed-author:NewmanRobert ARA,
pubmed-author:ShenYehuaY,
pubmed-author:ThorntonBobB,
pubmed-author:YangPeiyingP,
pubmed-author:ZhangYingY
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
115
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5309-18
|
|
pubmed:dateRevised |
2011-9-26
|
|
pubmed:meshHeading |
pubmed-meshheading:19701908-Aged,
pubmed-meshheading:19701908-Amphibian Venoms,
pubmed-meshheading:19701908-Antineoplastic Agents,
pubmed-meshheading:19701908-Carcinoma, Hepatocellular,
pubmed-meshheading:19701908-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:19701908-Female,
pubmed-meshheading:19701908-Humans,
pubmed-meshheading:19701908-Liver Neoplasms,
pubmed-meshheading:19701908-Lung Neoplasms,
pubmed-meshheading:19701908-Male,
pubmed-meshheading:19701908-Medicine, Chinese Traditional,
pubmed-meshheading:19701908-Middle Aged,
pubmed-meshheading:19701908-Pancreatic Neoplasms,
pubmed-meshheading:19701908-Pilot Projects
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer.
|
|
pubmed:affiliation |
International Center of Integrative Oncology, Fudan University Cancer Hospital, Shanghai, China.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase I,
Research Support, N.I.H., Extramural
|
